gabexate has been researched along with Intracranial Aneurysm in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Intracranial Aneurysm: Abnormal outpouching in the wall of intracranial blood vessels. Most common are the saccular (berry) aneurysms located at branch points in CIRCLE OF WILLIS at the base of the brain. Vessel rupture results in SUBARACHNOID HEMORRHAGE or INTRACRANIAL HEMORRHAGES. Giant aneurysms (
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toyoda, O | 1 |
| Nojiri, K | 1 |
| Nakajima, H | 1 |
1 other study available for gabexate and Intracranial Aneurysm
| Article | Year |
|---|---|
[Studies of two cases of ruptured intracranial aneurysm with disseminated intravascular coagulation].
Topics: Aged; Anticoagulants; Disseminated Intravascular Coagulation; Female; Gabexate; Guanidines; Humans; | 1989 |